131 related articles for article (PubMed ID: 34689564)
1. A metabolomic signature of FIGO stage I and II endometrial cancer.
Gu M; Chen X; Sun Y; Wang L; Shu H; Qian C
Neoplasma; 2021 Nov; 68(6):1283-1291. PubMed ID: 34689564
[TBL] [Abstract][Full Text] [Related]
2. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
6. Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.
Yi R; Xie L; Wang X; Shen C; Chen X; Qiao L
Front Oncol; 2022; 12():861142. PubMed ID: 35574395
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics in endometrial cancer diagnosis: A systematic review.
Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
[TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
10. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
11. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer.
Benabdelkamel H; Jaber MA; Akkour K; AlMalki RH; Alfadda AA; Masood A; Joy SS; Alhalal H; Alwehaibi MA; Arafah M; Alshehri E; Abdel Rahman AM
Metabolites; 2024 Feb; 14(2):. PubMed ID: 38393001
[TBL] [Abstract][Full Text] [Related]
13. Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.
Audet-Delage Y; Grégoire J; Caron P; Turcotte V; Plante M; Ayotte P; Simonyan D; Villeneuve L; Guillemette C
J Steroid Biochem Mol Biol; 2018 Apr; 178():45-54. PubMed ID: 29092787
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.
Akkour K; Alanazi IO; Alfadda AA; Alhalal H; Masood A; Musambil M; Rahman AMA; Alwehaibi MA; Arafah M; Bassi A; Benabdelkamel H
Cells; 2022 Jul; 11(13):. PubMed ID: 35805203
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract][Full Text] [Related]
18. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
[TBL] [Abstract][Full Text] [Related]
19. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotyping to monitor chronic enteritis canceration.
Zhang F; Li C; Deng K; Wang Z; Zhao W; Yang K; Yang C; Rong Z; Cao L; Lu Y; Huang Y; Han P; Li K
Metabolomics; 2020 Feb; 16(3):29. PubMed ID: 32095917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]